課程資訊
課程名稱
博士專題研究
Seminar 
開課學期
102-2 
授課對象
醫學工程學研究所  
授課教師
謝銘鈞 
課號
Biomed8001 
課程識別碼
548 D0020 
班次
10 
學分
全/半年
半年 
必/選修
選修 
上課時間
 
上課地點
 
備註
總人數上限:30人 
Ceiba 課程網頁
http://ceiba.ntu.edu.tw/1022Biomed8001_10 
課程簡介影片
 
核心能力關聯
核心能力與課程規劃關聯圖
課程大綱
為確保您我的權利,請尊重智慧財產權及不得非法影印
課程概述

博士專題研究:進度報告與文獻分享 

課程目標
引導學生完成研究成果 
課程要求
1.每星期挑選一主題報告與同學進行討論。
2.同學分享每星期實驗進度,並由老師給予改善建議。 
預期每週課後學習時數
 
Office Hours
 
指定閱讀
無 
參考書目
無 
評量方式
(僅供參考)
 
No.
項目
百分比
說明
1. 
口頭報告 
50% 
報告說明 
2. 
實驗進度 
50% 
實驗的進度掌握 
 
課程進度
週次
日期
單元主題
第2週
2/25  1.Indocyanine Green-Loaded Photoacoustic Nanodroplets: Dual Contrast Nanoconstructs for Enhanced Photoacoustic and Ultrasound Imaging
2.Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery(核心能力:2,3,7) 
第3週
3/4  1.Enhanced Introduction of Gold Nanoparticles into Vital Acidothiobacillus ferrooxidans by Carbon Nanotube-based Microwave Electroporation
2.Highly Efficient Hierarchical Micelles Integrating Photothermal Therapy(核心能力:2,3,7) 
第4週
3/11  1.Tuning, inhibiting and restoring the enzyme mimetic activities of Pt–apoferritin
2.Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier(核心能力:2,3,7) 
第5週
3/18  1.Targeted Theranostic Platinum(IV) Prodrug with a Built-In Aggregation-Induced Emission Light-Up Apoptosis Sensor for Noninvasive Early Evaluation of Its Therapeutic Responses in Situ
2.Photochemical internalization (PCI) of immunotoxins targeting CD133 is specific and highly potent at femtomolar levels in cells with cancer stem cell properties.(核心能力:2,3,7) 
第6週
3/25  1.Ability of Procalcitonin to Discriminate Infection from Non-Infective Inflammation Using Two Pleural Disease Settings
2.Dual imaging-guided photothermal/photodynamic therapy using micelles.(核心能力:2,3,7) 
第7週
4/1  1.Bidirectional developmental potential in reprogrammed cells with acquired pluripotency
2.Preclinical antitumor activity of a nanoparticulate SN38(核心能力:2,3,7) 
第8週
4/8  1.Gold Nanoshelled Liquid Perfluorocarbon Magnetic Nanocapsules: a Nanotheranostic Platform for Bimodal Ultrasound/Magnetic Resonance Imaging Guided Photothermal Tumor Ablation
2.Drug Delivery with PEGylated MoS2 Nano-sheets for Combined Photothermal and Chemotherapy of Cancer 
第9週
4/15  期中考- 暫停一次 
第10週
4/22  1.Nanographene Oxide–Hyaluronic Acid Conjuga
te for Photothermal Ablation Therapy of Skin Cancer(核心能力:2,3,7) 
第11週
4/29  1.Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin. (核心能力:2,3,7)
2.Hydrogel-nanoparticle composites for optically modulated cancer therapeutic delivery. 
第12週
5/6  1.Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
2.Oligonucleotides--assembled Au nanorod-assisted cancer photothermal ablation and combination chemotherapy with targeted dual-drug delivery of Doxorubicin and Cisplatin prodrug.(核心能力:2,3,7) 
第13週
5/13  1.Poly(lactide-co-glycolide) microspheres for MRI-monitored transcatheter delivery of sorafenib to liver tumors.
2.Efficacy of tigecycline pleurodesis: a comparative experimental study.(核心能力:2,3,7) 
第14週
5/20  1.Redox-Responsive, Core-Cross-Linked Micelles Capable of On-Demand, Concurrent Drug Release and Structure Disassembly
2.Immortalization of Erythroblasts by c-MYC and BCL-XL Enables Large-Scale Erythrocyte Production from Human Pluripotent Stem Cells(核心能力:2,3,7) 
第15週
5/27  1.Transdermal delivery of hyaluronic acid -- human growth hormone conjugate.
2.A gold nanoshell with a silica inner shell synthesized using liposome templates for doxorubicin loading and near-infrared photothermal therapy(核心能力:2,3,7) 
第16週
6/3  1. Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery 2. Improving drug accumulation and photothermal efficacy in tumor depending on size of ICG loaded lipid-polymer nanoparticles(核心能力:2,3,7) 
第17週
6/10  1.Phenylboro ic Acid - Installed Polymeric Micelles for Targeting Sialylated Epitopes in Solid Tumors 2. Prolonged blood circulation and enhanced tumor accumulation of folate-targeted dendrimer-polymer hybrid nanoparticles(核心能力:2,3,7) 
第18週
6/17  期末考週-暫停一次